Drugwatch FAQ

To keep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.

Drugwatch offers trustworthy information on the risks of certain prescription drugs and medical devices. If people need legal help, we connect them with experienced drug and device lawyers from national law firms.

We also assist journalists, media and researchers by giving them the whole picture on a potentially dangerous drug or medical device. Our in-house expert writers and researchers are available for interviews. We can also provide the stories of people harmed by drugs and devices.

1 South Orange Ave.,
Suite 201
Orlando, FL 32801

2009

Drugwatch’s main email address is [email protected] We check this inbox regularly. Once we receive your email, one of our writers will respond to you within about two to three business days.

You may also email one of our writers directly. All of the pages and news posts on Drugwatch.com are attributed to a writer. Anyone can contact a writer through email links on these pages or through email links on his or her individual bio page.

You may write to Drugwatch or any of our writers at this address:

Drugwatch
1 South Orange Ave., Suite 201
Orlando, FL 32801

Drugwatch is not a law firm, and our staff cannot give legal advice. But we can connect you with our legal partners. Visitors to Drugwatch.com can sign up for a free case review to speak with experienced drug and device lawyers from recognized national law firms.

Drugwatch does not charge for services or receive money from advertising. Wilson and Peterson, LLP — a Florida-based, mass-torts law firm — sponsors the website and pays the operating costs.

Wilson and Peterson, LLP is a law firm that specializes in mass torts. Specifically, the firm’s focus is on complex litigation for consumers injured by negligent companies.

Brian Wilson oversees the firm’s operations and has spent close to two decades leading clients through challenging legal matters. He is licensed to practice law in Washington, D.C. and Florida.

While the firm funds Drugwatch, there is no requirement to be a client of Wilson and Peterson, LLP to use Drugwatch’s services.

Drugwatch’s staff is made up of writers, outreach professionals and website designers. The site’s writers come from various professional backgrounds including newspapers, TV, magazines and universities. The designers work together with the writers to deliver information that is comprehensive and easy to understand. The outreach team makes connections with likeminded professionals to spread awareness about potentially dangerous drugs and medical devices.

Drugwatch does not employ doctors or licensed medical professionals, so it does not provide medical advice. Nothing presented on Drugwatch is a substitute for the advice of a doctor or other licensed health care provider.

People who are interested in speaking with a lawyer about their injuries can fill out a free case review form on Drugwatch.com. Drugwatch sends the forms to its legal partners.

A law firm representative will call the phone number provided in the form to conduct a free case review. Visitors to Drugwatch.com can also call the phone number listed on our site to speak with a law firm representative.

Drugwatch never spams any of our site visitors or engages in predatory practices to sign people up for lawsuits. If site visitors do not wish to sign up for a lawsuit, they can still use all the information Drugwatch offers.

No. Case reviews and use of the website are free to site visitors.

A representative from one of the law firms Drugwatch partners with will ask you questions about you or your loved one’s injuries and the drug or medical device in question. The representative will let you know whether the law firm is able to handle a case like yours.

The law firm may send you a retainer. This is a legal contract to represent a potential client. Until the contract is signed and returned, the firm cannot act on a client’s behalf.

At this point, the firm does not share any information with Drugwatch, and our staff has no access to information pertaining to a particular case. For status updates, always contact the law firm directly.

Drugwatch gets its information from peer-reviewed medical journals, trusted news outlets, expert interviews and government reports.

Yes, our writers are available for interviews, podcasts and email commentary.

Drugwatch is committed to protecting your privacy. In order to use Drugwatch’s services, visitors voluntarily supply the information requested on the site such as name, address, telephone number and email address. This information is only used to provide you with the service you requested, such as a free case review.

Although we may use your email address to send you news or contact you about Drugwatch services, the site will not share any personal information with a third party unless the visitor authorizes it. For more detailed information, please review Drugwatch’s privacy policy.

Anything shared with Drugwatch is private. If the site would like to publish a story on the website to help others understand the dangers of a drug or medical device, a writer will ask permission to do so. On some occasions, our writers will also ask if someone who shared their story with Drugwatch would be willing to speak to professional journalists.